Synchron is pioneering minimally invasive brain-computer interfaces (BCIs) to restore communication, mobility, and independence for people with paralysis. Its Stentrode™ platform is the first endovascular BCI designed to translate thought into digital action without open-brain surgery, combining neurointerventional access, device engineering, and NeuroAI to create scalable, real-world neural interfaces.